Answers are grounded in this paper and cite their sources.
No direct evidence conclusively supports the efficacy of shorter (18-24 hour) fasting tests for diagnosing insulinomas when compared to the standard 72-hour test. While shorter tests may be sensitive, comprehensive evidence remains incomplete.
No takes yet. Share an insight, caveat, or question.
Tripdatabase (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: